PeopleofSuperintelligence

Researcher

Ariel Fernández

Also known as Ariel Fernández Stigliano

Ariel Fernández is a molecular biophysicist whose work connects AI with drug design and molecular medicine. He studied at the Universidad Nacional del Sur, earned a Yale doctorate in physical chemistry in 1984, and worked at Max Planck from 1986 to 1989. He received a Guggenheim fellowship in 1995, introduced the dehydron with Ridgway Scott in 2003, and held the Hasselmann engineering chair at Rice from 2005 to 2011. His AI work included a transformer paper and a molecular-therapy book in 2021, followed by a July 2025 book on formal autoencoders and quantum cosmology. As of October 2026, he is a principal researcher at INQUISUR; HHS made its research-misconduct findings final in May 2025 and debarred him from covered transactions for 15 years in March 2026.

Now at
National Scientific and Technical Research Council
Works
500

Publication numbers from OpenAlex, as of 18 October 2026. Citations and h-index are hidden because this OpenAlex record may be incomplete or mix in other authors.

Timeline

  1. 1975–1984

    From Argentina to Yale

    He studies at the Universidad Nacional del Sur from 1975 to 1979 and earns a Ph.D. in physical chemistry at Yale University in 1984.

  2. 1986–1989

    At the Max Planck Institute

    He serves as a senior research scientist in Manfred Eigen's division at the Max Planck Institute for Biophysical Chemistry in Göttingen from 1986 to 1989.

  3. 1995

    A Guggenheim fellowship

    He receives a John S. Guggenheim Memorial Foundation fellowship in 1995.

  4. 2003–2011

    Dehydrons and the Rice chair

    In 2003, he and Ridgway Scott introduce the dehydron, a defectively packed backbone hydrogen bond linked to protein-protein interactions. He holds Rice University's Karl F. Hasselmann Chaired Professor of Engineering role from 2005 to 2011.

  5. 2021

    AI for molecular drug design

    In 2021, he publishes the transformer-based paper Artificial Intelligence Deconstructs Drug Targeting In Vivo by Leveraging a Transformer Platform and the book Artificial Intelligence Platform for Molecular Targeted Therapy: A Translational Science Approach.

  6. May 2025–July 2025

    An AI cosmology book

    In May 2025, an HHS administrative law judge recommends summary judgment in favor of HHS. The Acting Assistant Secretary for Health declines review, making ORI's research-misconduct findings final. In July 2025, he publishes De Novo Quantum Cosmology with Artificial Intelligence: Applications of Formal Autoencoders and serves as the CSO of the Daruma Institute for Applied Intelligence.

  7. March 2026

    A 15-year debarment

    HHS debars him from covered transactions for 15 years, beginning in March 2026.

  8. As of October 2026

    Principal researcher at INQUISUR

    As of October 2026, he is a principal researcher at CONICET's INQUISUR, with current work on biomolecular interfaces and an AI platform for molecular medicine.

Career

  1. NowNational Scientific and Technical Research CouncilPrincipal Researcher
  2. 2025Daruma Institute for Applied IntelligenceCSO
  3. 2005–2011Rice UniversityKarl F. Hasselmann Chaired Professor of Engineering
  4. 1986–1989Max Planck Institute for Multidisciplinary SciencesSenior Research Scientist

Education

  1. 1984Yale UniversityPhD
  2. 1979National University of the South

From the biography.

  1. Stanford University trained or employed 27 of the 111 AI major-prize winners, more than any other universityIncludes Princeton University. Stanford University trained or employed 27 of the 111 AI major-prize winners, more than any other university. We compare doctorate and employment links for major-prize and best-paper winners.
  2. Google has the highest combined h-index among AI organizationsIncludes Max Planck Society. Our estimates of combined and median h-index at AI organizations, using current affiliations and OpenAlex records.
  3. More people shaping AI studied at Massachusetts Institute of Technology than at any other institutionIncludes Princeton University. Our estimates of where the people shaping AI studied and where their careers led, from education records in cited biographies.
  4. The company share of AI researchers’ top papers rose from 3% to 32%Includes Max Planck Society. We estimate where leading AI researchers worked when their most-cited papers appeared. The company share rose from 3% in 1975–1979 to 32% in 2020–2024.

Colleagues

People with dated positions at the same organization in the same years.

Sources and credits

Photo: We have no published photo of Ariel Fernández yet. Send us a free-licensed photo.

  1. ARIEL FERNANDEZ - CONICET bicyt.conicet.gov.ar. Checked 18 October 2026.
  2. Ariel Fernandez Stigliano CV profarielfernandez.com. Checked 18 October 2026.
  3. Ariel Fernandez CV - AI Science Chemical Physics arielfernandez.net. Checked 18 October 2026.
  4. Dehydron: A Structurally Encoded Signal for Protein Interaction - PMC pmc.ncbi.nlm.nih.gov. Checked 18 October 2026.
  5. Artificial Intelligence Deconstructs Drug Targeting In Vivo by Leveraging a Transformer Platform - PMC pmc.ncbi.nlm.nih.gov. Checked 18 October 2026.
  6. Ariel Fernandez Artificial Intelligence profarielfernandez.com. Checked 18 October 2026.
  7. Case Summary: Fernandez, Ariel | ORI - The Office of Research Integrity ori.hhs.gov. Checked 18 October 2026.
  8. Chapman & Hall/CRC Artificial Intelligence and Robotics Series - Book Series - Routledge & CRC Press routledge.com. Checked 18 October 2026.
  9. De Novo Quantum Cosmology with Artificial Intelligence Applications of Formal Autoencoders routledge.com. Checked 18 October 2026.